+ All Categories
Home > marketing authorisation
Marketing authorization procedures in eu
Marketing authorization procedures in eu
2.986 views
Good Guide
Good Guide
43 views
SARQA/DKG Conference 3-4 October 2002 1 SARQA/DKG Conference 3-4 OCTOBER 2002 Annex 13 Update An Industry Perspective Michael J Cooke Director, Global.
SARQA/DKG Conference 3-4 October 2002 1 SARQA/DKG Conference 3-4 OCTOBER 2002 Annex 13 Update An Industry Perspective Michael J Cooke Director, Global.
213 views
Kiev, 04/12/2007 Analysis of EU MRP/DCP procedures regarding to generic applications Dr.Raimonds Lozda, FMS Baltic Ltd.
Kiev, 04/12/2007 Analysis of EU MRP/DCP procedures regarding to generic applications Dr.Raimonds Lozda, FMS Baltic Ltd.
215 views
Advanced Therapy Regulation Hearing, Brussels May 11, 2006 Dr.Andreas Reimann CEO, Mukoviszidose e.V. (German Cystic Fibrosis Association) Vice-Chairman,
Advanced Therapy Regulation Hearing, Brussels May 11, 2006 Dr.Andreas Reimann CEO, Mukoviszidose e.V. (German Cystic Fibrosis Association) Vice-Chairman,
215 views
22nd May 2007 EURS Implementation Group Terms of Reference and Roadmap.
22nd May 2007 EURS Implementation Group Terms of Reference and Roadmap.
214 views
© WHO – PSM Validations –part 2 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm.
© WHO – PSM Validations –part 2 Workshop on GMP and Quality Assurance of TB products Kuala Lumpur Malaysia, 21 – 25 February 2005 Maija Hietava M.Sci.Pharm.
214 views
IRESSA Dr Rose McCormack Personalised Healthcare AstraZeneca A Presentation for the Translational Genomics Meeting Royal College of Physicians, London.
IRESSA Dr Rose McCormack Personalised Healthcare AstraZeneca A Presentation for the Translational Genomics Meeting Royal College of Physicians, London.
220 views
VTM Virtual Therapeutic Moeity Actual Therapeutic Moeity ATM VMP Virtual Medicinal Product AMP Actual Medicinal Product AMPP Actual Medicinal Product Package.
VTM Virtual Therapeutic Moeity Actual Therapeutic Moeity ATM VMP Virtual Medicinal Product AMP Actual Medicinal Product AMPP Actual Medicinal Product Package.
233 views
From POM to P From POM to P Wellard’s NHS training wellards.co.uk 2004.
From POM to P From POM to P Wellard’s NHS training wellards.co.uk 2004.
213 views
Groupings: Several Type IA or IA IN affecting one MA One Type IA or change affecting several MAs from the same MAH Tightening of specification limits (change.
Groupings: Several Type IA or IA IN affecting one MA One Type IA or change affecting several MAs from the same MAH Tightening of specification limits (change.
221 views
Sicurezza e segnalazione degli eventi avversi: antibiotici, antinfiammatori, antidolorifici, stati febbrili. Effetto Nocebo del farmaco Achille P. Caputi.
Sicurezza e segnalazione degli eventi avversi: antibiotici, antinfiammatori, antidolorifici, stati febbrili. Effetto Nocebo del farmaco Achille P. Caputi.
216 views